Journal of the American Academy of Dermatology
Volume 63, Issue 2 , Pages 219-227 , August 2010

Retrospective analysis of drug-induced hypersensitivity syndrome: A study of 27 patients

,Accepted 29 August 2009.

References 

  1. Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS). Semin Cutan Med Surg. 1996;15:250–257
  2. Mansur AT. Pekcan Yaşar S, Göktay F. Anticonvulsant hypersensitivity syndrome: clinical and laboratory features. Int J Dermatol. 2008;47:1184–1189
  3. Vauthey L, Uçkay I, Abrassart S, Bernard L, Assal M, Ferry T, et al. Vancomycin-induced DRESS syndrome in a female patient. Pharmacology. 2008;82:138–141
  4. Lee JH, Park HK, Heo J, Kim TO, Kim GH, Kang DH, et al. Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome induced by celecoxib and anti-tuberculosis drugs. J Korean Med Sci. 2008;23:521–525
  5. Knowles SR, Shapiro L, Shear NH. Serious adverse reactions induced by minocycline: report of 13 patients and review of the literature. Arch Dermatol. 1996;132:934–939
  6. Bourezane Y, Salard D, Hoen B, Vandel S, Drobacheff C, Laurent R. DRESS (drug rash with eosinophilia and systemic symptoms) syndrome associated with nevirapine therapy. Clin Infect Dis. 1998;27:1321–1322
  7. Prussick R, Shear NH. Dapsone hypersensitivity syndrome. J Am Acad Dermatol. 1996;35:346–349
  8. Morimoto T, Sato T, Matsuoka A, Sakamoto T, Ohta K, Ando T, et al. Trimethoprim-sulfamethoxazole-induced hypersensitivity syndrome associated with reactivation of human herpesvirus-6. Intern Med. 2006;45:101–105
  9. Lupton GP, Odom RB. The allopurinol hypersensitivity syndrome. J Am Acad Dermatol. 1979;1:365–374
  10. Le Nouail P, Viseux V, Chaby G, Billet A, Denoeux JP, Lok C. Drug reaction with eosinophilia and systemic symptoms (DRESS) following imatinib therapy. Ann Dermatol Venereol. 2006;133:686–688
  11. White JM, Smith CH, Robson A, Ash G, Barker JN. DRESS syndrome caused by efalizumab. Clin Exp Dermatol. 2008;33:50–52
  12. Kucharewicz I, Kemona-Chetnik I, Reduta T, Wierzbicka I, Flisiak R, Bodzenta-Lukaszyk A. Drug rash with eosinophilia and systemic symptoms after ibuprofen intake. J Investig Allergol Clin Immunol. 2007;17:347–348
  13. Bankar RN, Köhnke A, Palani SB. Drug rash with eosinophilia and systemic symptoms syndrome due to quinine. J Postgrad Med. 2007;53:272–273
  14. Brooks H, Taylor HG, Nichol FE. The three week sulfasalazine syndrome. Clin Rheumatol. 1992;11:566–568
  15. Norgard N, Wall GC. Possible drug rash with eosinophilia and systemic symptoms syndrome after exposure to epoetin alfa. Am J Health Syst Pharm. 2005;62:2524–2526
  16. Bagshaw SM, Cload B, Gilmour J, Leung ST, Bowen TJ. Drug-induced rash with eosinophilia and systemic symptoms syndrome with bupropion administration. Ann Allergy Asthma Immunol. 2003;90:572–575
  17. Peyrie`re H, Dereure O, Breton H, Demoly P, Cociglio M, Blayac JP, et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?. Br J Dermatol. 2006;155:422–428
  18. Bonnetblanc JM. Drug hypersensitivity syndrome. Dermatology. 1993;187:84–85
  19. Shiohara T, Iijima M, Ikezawa Z, Hashimoto K. The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Br J Dermatol. 2007;156:1083–1084
  20. Sontheimer RD, Houpt KR. DIDMOHS. a proposed consensus nomenclature for the drug-induced delayed multiorgan hypersensitivity syndrome. Arch Dermatol. 1998;134:874–876
  21. Kardaun SH, Sidoroff A, Valeyrie-Allanore L, Halevy S, Davidovici BB, Mockenhaupt M, et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?. Br J Dermatol. 2007;156:609–611
  22. Chiou CC, Yang LC, Hung SI, Chang YC, Kuo TT, Ho HC. Clinicopathological features and prognosis of drug rash with eosinophilia and systemic symptoms: a study of 30 cases in Taiwan. J Eur Acad Dermatol Venereol. 2008;22:1044–1049
  23. Sullivan JR, Shear NH. The drug hypersensitivity syndrome: what is the pathogenesis?. Arch Dermatol. 2001;137:301–304
  24. Hirsch LJ, Arif H, Nahm EA, Buchsbaum R, Resor SR, Bazil CW. Cross-sensitivity of skin rashes with antiepileptic drug use. Neurology. 2008;71:1527–1534
  25. Slatore CG, Tilles SA. Sulfonamide hypersensitivity. Immunol Allergy Clin North Am. 2004;24:477–490
  26. Sago J, Hall RP. Dapsone. Dermatol Ther. 2002;15:340–351
  27. Eshki M, Allanore L, Musette P, Milpied B, Grange A, Guillaume JC, et al. Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure. Arch Dermatol. 2009;145:67–72
  28. Zuliani E, Zwahlen H, Gilliet F, Marone C. Vancomycin-induced hypersensitivity reaction with acute renal failure: resolution following cyclosporine treatment. Clin Nephrol. 2005;64:155–158
  29. Brown RJ, Rother KI, Artman H, Mercurio MG, Wang R, Looney RJ, et al. Minocycline-induced drug hypersensitivity syndrome followed by multiple autoimmune sequelae. Arch Dermatol. 2009;145:63–66
  30. Gupta A, Eggo MC, Uetrecht JP, Cribb AE, Daneman D, Rieder MJ, et al. Drug-induced hypothyroidism: the thyroid as a target organ in hypersensitivity reactions to anticonvulsants and sulfonamides. Clin Pharmacol Ther. 1992;51:56–67
  31. Kano Y, Hiraharas K, Sakuma K, Shiohara T. Several herpesviruses can reactivate in a severe drug-induced multiorgan reaction in the same sequential order as in graft-versus-host disease. Br J Dermatol. 2006;155:301–306
  32. Descamps V, Mahe E, Houhou N, Abramowitz L, Rozenberg F, Ranger-Rogez S, et al. Drug-induced hypersensitivity syndrome associated with Epstein-Barr virus infection. Br J Dermatol. 2003;148:1032–1034
  33. Seishima M, Yamanaka S, Fujisawa T, Tohyama M, Hashimoto K. Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome. Br J Dermatol. 2006;155:344–349
  34. Tohyama M, Hashimoto K, Yasukawa M, Kimura H, Horikawa T, Nakajima K, et al. Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome. Br J Dermatol. 2007;157:934–940

 Funding sources: None.

 Conflicts of interest: None declared.

PII: S0190-9622(09)01206-7

doi: 10.1016/j.jaad.2009.08.050

Journal of the American Academy of Dermatology
Volume 63, Issue 2 , Pages 219-227 , August 2010

Article Tools

* Image Usage & Resolution